What is rapamycin used for
Organ rejection happens when the immune system treats the new organ as an invader and attacks it.The small clinical trial found that regular application of rapamycin to the backs of the hands.Vation of t cells upon association.Rapamycin has been used for many years as an immunosuppressant drug to prevent organ transplant rejection.Rapamycin (rapamune, sirolimus) is a macrolide exhibiting potent antitumor and immunosuppressive activity [261,262].Rapamycin immunosuppressant actions result from the inhibition of t and b cell proliferation through the same mechanisms that rapamycin blocks cancer cell proliferation.
Sirolimus, also known as rapamycin, sold under brand names such as rapamune, is a macrolide compound used to cover coronary stents, prevent organ transplant rejection, treat rare lung diseases called lymphangioleiomyomatosis, and treat perivascular epithelioid cell tumors (pecoma) it has an immunosuppressive function in the human body and is …Rapamycin is thus used in clinical settings to prevent rejection in organ transplantation and to treat certain types of cancer.It is also used to coat coronary stents and to treat the rare lung disease lymphangioleiomyomatosis.Transdermal rapamycin cream bypasses the digestive process increasing absorption and bioavailability.The earliest and most common pharmacological use of rapamycin is as an immune.Rapamycin (rapamune, sirolimus) is a macrolide exhibiting potent antitumor and immunosuppressive activity [261,262].